Corona vaccine: criticism of Russian study
Ana Goldscheider studied journalism and corporate communication in Hamburg and is now completing additional training as an editor. In a medical editorial office, she writes texts for print magazines and, among other things.
More about the experts All content is checked by medical journalists.International scientists have concerns about the first study on the "Sputnik V" corona vaccine. Regardless of this, the search for a suitable vaccine candidate continues. The federal government expects the first vaccines at the beginning of next year.
After the publication of a study on the new Russian corona vaccine with the name "Sputnik V" in the medical journal "The Lancet", international criticism is raining from researchers. Because of the many questions, the journal has now called on the authors of the Russian vaccination study to comment. You were invited to answer open questions, said a spokeswoman for the journal on Wednesday of the German press agency. "We are still closely monitoring the situation."
Doubts about the study
The background is an open letter from around 40 international scientists. In it you express considerable doubts about the study. In their view, "the presentation of the data raises some concerns". The researchers working with molecular biologist Enrico Bucci are demanding that Moscow access the original data for a full investigation. The population's expectations of an effective vaccine are understandably high, it said to justify.
The serum against the coronavirus developed in Russia was the first in the world to be approved for widespread use in the population. Even after the approval in mid-August, there was international criticism: It took place before the completion of important tests. The Russian team had published their study on the vaccine at the beginning of the month in the journal "The Lancet".
Inconclusive data
"The data contains very strange patterns," Bucci told the Moscow Times portal. For example, he referred to results describing the formation of antibodies. There are the same values for different groups of patients. So many duplicates are highly unlikely, he said. "It's like throwing a dice and getting exactly the same sequence of numbers several times."
The Russian state agency Tass reported that the developers of the vaccine in Moscow had already sent answers to questions that were "of interest to their Western colleagues". According to the Russian version, the vaccine produces antibodies. It is also free from serious side effects, according to the Russian researchers.
Vaccine in early 2021?
According to the World Health Organization, around 170 projects around the world are currently looking for an effective substance. According to this, test vaccinations are already running in 26 projects in order to examine the health compatibility and effectiveness.
The federal government expects a vaccine against the coronavirus in Germany to be available for parts of the population in the first few months of next year, but for the broad masses probably not until the middle of the year.
The Standing Vaccination Commission (STIKO) at the Robert Koch Institute assumes that there will be several different vaccines against the new coronavirus in Germany. It could be that individual vaccines are particularly suitable for certain population groups - for example for the elderly. (ag / dpa)
Tags: diet menopause womenshealth
